Literature DB >> 10452622

Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease.

C A Jantos1, A Nesseler, W Waas, W Baumgärtner, H Tillmanns, W Haberbosch.   

Abstract

Coronary atherectomy specimens from 50 patients with coronary heart disease were examined for the presence of Chlamydia pneumoniae by two different methods of polymerase chain reaction (PCR) and by in situ hybridization. C. pneumoniae DNA was detected by PCR in atherosclerotic plaques of four patients (8%). Two patients' coronary atheromas were positive, both by a single-step 16S rRNA-based PCR and by an omp1-based nested PCR. The other two patients' specimens were positive only by the nested PCR. In contrast, C. pneumoniae was not detected by in situ hybridization in any of the cardiovascular tissues tested. Of three patients with evidence of C. pneumoniae in coronary atheromas, two had an antibody titer of 1:32 and the third had no specific antibodies detectable. Results of this study demonstrate a low prevalence of C. pneumoniae DNA in coronary atheromas. These findings do not support the hypothesis that the organism plays a major role in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452622     DOI: 10.1086/514763

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.

Authors:  P Apfalter; F Blasi; J Boman; C A Gaydos; M Kundi; M Maass; A Makristathis; A Meijer; R Nadrchal; K Persson; M L Rotter; C Y Tong; G Stanek; A M Hirschl
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Is Mycoplasma pneumoniae associated with vascular disease?

Authors:  B Maraha; A van Der Zee; A M Bergmans; M Pan; M F Peeters; H F Berg; G J Scheffer; J A Kluytmans
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 4.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

5.  Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae.

Authors:  Maria Lucia C Tondella; Deborah F Talkington; Brian P Holloway; Scott F Dowell; Karyn Cowley; Montse Soriano-Gabarro; Mitchell S Elkind; Barry S Fields
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 6.  Chronic infections and atherosclerosis/thrombosis.

Authors:  Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

7.  Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.

Authors:  E Podsiadły; J Przyłuski; A Kwiatkowski; M Kruk; M Wszoła; R Nosek; W Rowiński; W Ruzyłło; S Tylewska-Wierzbanowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

Review 8.  Atherosclerosis: humoral and cellular factors of inflammation.

Authors:  A C Langheinrich; R M Bohle
Journal:  Virchows Arch       Date:  2005-02-02       Impact factor: 4.064

Review 9.  Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.

Authors:  I W Fong
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

10.  Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein.

Authors:  Marcus Klein; Arne Kötz; Katussevani Bernardo; Martin Krönke
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.